silvia f. costa dmip-fmusp [email protected]/wp-content/uploads/2017/10/31.pdf · ipc in...
TRANSCRIPT
![Page 2: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/2.jpg)
IPCinHematology
Epidemiology• SiteofInfecDons• RiskFactors• ColonizaDonxInfecDon• Bacteria,Virus,Fungi
Denominator• Neutropenia-days
IntervenDons
![Page 3: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/3.jpg)
RiskfactorsHCAIinHematologyCVCChemotherapyMucositeNeutropeniaCrossTransmissionATBBMTptsGVHD
![Page 4: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/4.jpg)
Virulancefactors HostFactors
esp
byl
acm
VRE
ATB
Gastric protector
Dialysis
CrossInfecDon
VRE BSI
Mucositis Neutropenia
GI Tract colonization
Translocation
![Page 5: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/5.jpg)
![Page 6: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/6.jpg)
![Page 7: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/7.jpg)
![Page 8: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/8.jpg)
![Page 9: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/9.jpg)
![Page 10: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/10.jpg)
CDC• 3,253Hospitais
CLABSIreported2014• 10%MBI-CLABSI
![Page 11: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/11.jpg)
![Page 12: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/12.jpg)
RestrospecDveStudy
374HSCT
MBI-LCBSIdefiniDon:
![Page 13: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/13.jpg)
374HSCTPts
BSIMBI-LCBSICLBSISecondaryBSI
17080(47%)68(40%)22(13%)
MBI-LCBSImorefrequentAlogeinicHSCT18%x7%p=0.07
![Page 14: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/14.jpg)
Klastersky J et al. Int J Antimicrob Agents 2007; 30 (suppl 1) S51-9 Freifeld et al. Clinical Practice Guideline. CID 2011; 52 (4) e56-93
BSIagentsFebrileNeutropenia
![Page 15: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/15.jpg)
BSIinNeutropenicpts
2001-2006 2008-2010
BGN 23% 84%
200EpisodesFebrileNeutropenia• 30%MicrobiologyConfirmed• 26%BSI• 30%HSCT
Ghosh et al. Med Oncol 2012;29:1354-60
![Page 16: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/16.jpg)
BGNFebrileNeutropeniaN (%)
Gram-negativo 44 (55.7%) P. aeruginosa 12 (15%) E. coli 11 (14%) Acinetobacter spp 10 (13%) Klebsiella spp 10 (13%) Gram-positivo 35 (44.3%) S. aureus 20 (25.4%) Enterococcus spp 8 (10%) CONS 6 (8%)
Ghosh et al. Med Oncol 2012;29:1354-60
R Carbapenem 80% Acinetobacter e 50% P. aeruginosa
![Page 17: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/17.jpg)
![Page 18: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/18.jpg)
HCAIinneutropenicptsHC-FMUSP424HSCT,5.988neutropeniadays
GN-43(54%)
GP-33(41%)
![Page 19: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/19.jpg)
![Page 20: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/20.jpg)
![Page 21: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/21.jpg)
PathogensurveillanceinHematology/BMTpts
Moulds
C.difficile
Respiratoryvirus
MDR
![Page 22: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/22.jpg)
REFORMAENFERMARIA
REFORMAENFERMARIA
IncidenceoffungiInfecQonsinBMtUNITHC-FMUSP
0"
20"
40"
60"
80"
100"
120"
140"
160"
180"
2007" 2008" 2009" 2010" 2011" 2012" 2013" 2014" 2015"Candidíase" 4,27" 0,00" 0,00" 9,71" 0,00" 17,24" 12,90" 8,55" 45,45"
Fusariose" 0,00" 0,00" 10,15" 9,71" 0,00" 0,00" 12,90" 0,00" 0,00"
Aspergilose" 4,27" 24,51" 25,38" 82,52" 34,97" 17,24" 161,29" 102,56" 136,36"
Galactomanan-IFI
GalactomananpreempQveIFI
ThoraxCT
1 1
5 52
17
2 2
5
3 3 2 2
25
12
3
1
1
![Page 23: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/23.jpg)
EPIDEMIOLOGYANDRISKFACTORSFORINFECTION
GraçaMG,vanderHeijdenIM,PerdigãoL,TairaC,CostaSF,LevinAS.EvaluaQonoftwomethodsfordirectdetecQonofFusariumspp.inwater.JMicrobiolMethods.2016Apr;123:39-43.LitvinovN,daSilvaMT,vanderHeijdenIM,GraçaMG,MarquesdeOliveiraL,FuL,GiudiceM,ZildadeAquinoM,Odone-FilhoV,MarquesHH,CostaSF,LevinAS.Anoutbreakofinvasivefusariosisinachildren'scancerhospital.ClinMicrobiolInfect.2015Mar;21(3):268.e1-7.
AlloHCTrecipients,otherhighlyimmunocompromisedpaDentsatincreasedriskforIAshouldbeplacedinaprotectedenvironment
• (strongrecommendaDon;low-qualityevidence).
LeukemiaandtransplantcentersshouldperformregularsurveillanceofcasesofinvasivemoldinfecDon. • (strongrecommendaDon;low-qualityevidence).
![Page 24: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/24.jpg)
MouldsinHematologyWards:intervenQons
SurveillanceWhen?
Cleaningofcoldwaterreservoirswithchlorine
conQnuouschlorinaQonofwater
0.2-μmfiltersinalltapfaucetsandshowers
Water,andairculture,PCR?
![Page 25: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/25.jpg)
MDRINHEMATOLOGYSETTINGIMPORTANTQUESTIONSTOASK:PREVIOUSHOSPITALIZATIONLASTYEAR?PREVIOUSUSEOFANTIBIOTICLASTYEAR?TRAVEL-ENDEMICCOUNTRIESMRSA,NDMCOLONIZATIONANDINFECTIONDUETOMDRCULTURESRESULTSCLASSIFYPATIENTRISK
• HematologicalptscolonizedbyVREover2years• Acinetobacter>42months• MRSAover6months
Marchaimetal.JClinMicrob2007,151-5Feldmanetal.JClinMicrob2013,19:190-6
![Page 26: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/26.jpg)
RiskFactorforMDRinHematologyandBMTpaDents
CVC
PreviousbroadspectrumanDbioDc
ICU MucosiDs/GVHD
PreviouscolonizaDon
Imunossupression
HSCT
Mikulskaetal.CurropinHematol2014;21:451-8VanDuinetal.JTranplant2013;13:31-41
Averbuchetal.Haematologica2013;98:12
Gram-NegaQve• Pseudomonas,Enterobacteria
Gram-posiQve• VRE,SCN
![Page 27: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/27.jpg)
WhichsiteshouldMDRscreeningbeperformed
RectalRespiratoryNaresInguinal
• MRSAX
• VREX
• CREXX
• AcinetobacterXX
• PseudomonasXX
• Gram-negaDve:morethan1siteincreasesposiDvityDalbenetal.JHI2010;74:395-411Taconelli.ClinMicrobInfect2014;1:1-55
![Page 28: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/28.jpg)
• RectalSwab• 3rectalswabs• 21/185(11%)ptswerecolonized
– 10E.coli– 5Pseudomonas– 4K.pneumoniae– Enterobacter– 1Stenotrophomonas– 1A.baumannii
24dayshospitalizaDontocolonizaDon
![Page 29: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/29.jpg)
MajorityspontaneousdecolonizaDon6monthsalerdischarged
1ptimunossupresion+anDbioDccolonized>3years
AmJInfectControl2014;42:376-80
![Page 30: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/30.jpg)
RiskfactorsmulDvariateanalysisRR(95%IC)PTransferfromanotherHospital7.8(2.0-31.2)0.003Transferbetweenunits9.3(27-31.9)<0.001Busulfan11.9(2.5-56)0.002Fludarabine6.4(1.5-27)0.011Centralvenouscatheter5.1(1.1-23.5)0.037
![Page 31: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/31.jpg)
65centers25countries• BSIpost-THSCTupto6months
RatesandRiskfactors
ResistanceGNR• Fluorquinolones• Carbapenems• MDR
![Page 32: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/32.jpg)
655episodesBSI-591pts
1.1episodes/pt(1-4episodes)
Resistance
• 50%fluorquinolones• 18%Carbapenems• 35%MDR
RF:DuraDonHospitalizaDon
![Page 33: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/33.jpg)
![Page 34: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/34.jpg)
VREHematologyWard
ColonizaDonxInfecDon
Onlyseveritymarker?
![Page 35: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/35.jpg)
Sómarcador
752ptsTCTH• 14%colonizaDon 7%InfecDon
93BSI1yearpost-THSCT66%VRE• RF:colonizaQonandneutropenia
30daysMortalitys 38%VRE=VSE
1yearsurvival
VRE 20%
VSE 48%
![Page 36: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/36.jpg)
![Page 37: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/37.jpg)
VRELinezolid-resistant• HSCT
• SuscepQbilityLinezolid
• 48casesx96controls• RFMVOR 95%ICP• PrevioususeLinezolid31.844,20-259<0.001
• Santayanaetal.DiagMicrobInfecDisJuly,2012
![Page 38: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/38.jpg)
• 89VREstrains2005-2014
• 78pts
• 1BSIisolateLinezolid-resistant
Isolates TotalE.faecalis
ColonizaQon 18
E.faecium 79
ColonizaQon 69
BloodstreaminfecQon 7
Pneumonia 2
SkinandsooQssue 1
Total 97
![Page 39: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/39.jpg)
![Page 40: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/40.jpg)
![Page 41: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/41.jpg)
• 127P.aeruginosaresistanttoCarbapenem• 12-year
– CarbapenemMIC:8-128– SuscepQbleonlytocolisQn– NewclusterBMT-2012
• IsolatesharboringKPC,VIM,SPM
• Outbreak-29casesBSI• Mortalityover70%(inpress)
![Page 42: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/42.jpg)
• PrevioushospitalizaDoninSerbia
• D+15allogeneicHSCTBSIshock
• ColisDn12/12hs-9milions
• D+17death
EuroSurveillance2013;18:46
![Page 43: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/43.jpg)
![Page 44: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/44.jpg)
PrevenDonandControlMDRintransplantaDon
ContactprecauQon
HandHygiene
BundlesprevenQonBSI-CVC,VAP,UTI
RatesFeedbackothersintervenQons
BoucherHW.ClinicalInfecTousDiseases.2010Taconellietal.ClinMicrobInfect2014;1:1-55
![Page 45: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/45.jpg)
AnDbioDcstewardshiptransplantaDonserng
BMT• ProphylaxisonlyforHighRiskpaQents• LeukemiaandAllogeneicHSCT
Febrileneutropenia• DuraQonanQbioQc• Avoidvancomycin
• DonottreatcolonizaDon
• De-escalaDon
![Page 46: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/46.jpg)
• 6monthsintervenDonxnon-intervenDon• 7727pts• 9ICU• 1BMT
![Page 47: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/47.jpg)
BSIratespreandpostChlorexedineBath
![Page 48: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/48.jpg)
HCAIratespreandpostChlorexedineBath
![Page 49: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/49.jpg)
![Page 50: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/50.jpg)
VREinfecDontemporalseriescomparingpreandpostintervenDoninBMTUNIT(2005-2009)x2009-2013HC-FMUSP,1.323pts
Den
sity
of V
RE
infe
ctio
n(/1
000
pt-d
ay)
02
46
810
1214
jan
05
jul 0
5
jan
06
jul 0
6
jan
07
jul 0
7
jan
08
jul 0
8
jan
09
jul 0
9
jan
10
jul 1
0
jan
11
jul 1
1
jan
12
jul 1
2
jan
13
jul 1
3
jan
14
INTERVENÇÃO
Model (0,0,4) (0,0,1)
Variable Betta SE P value
Constant 0.557 0.564 0.326
Secular 0.054 0.018 0.003
Intervention -1.429 0.813 0.082
Post-intervention
-0.086 0.025 0.001
- - - TaxasobservadasModelocompleto
- - - Previsãosemaintervenção
- - - Previsãocomaintervenção
- - - Momentodaintervenção
VRE-INF
• Gram-negaDveratesincreased• VREChlorhexidineMIC
Chlorhexidinebath
![Page 51: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/51.jpg)
![Page 52: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/52.jpg)
TMOHC-FMUSPJanuary-March2015
![Page 53: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/53.jpg)
PCR16SRibosomic
![Page 54: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/54.jpg)
![Page 55: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/55.jpg)
![Page 56: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/56.jpg)
![Page 57: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/57.jpg)
![Page 58: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/58.jpg)
![Page 59: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/59.jpg)
• Outbreak 2008 • BMT Unit, Israel • Colonization and BSI
Oral Genta 80mg Up to erradication
• Erradication: 03 negatives rectal swabs weekly
KPCHSCT
15 pts colonized KPC
5 months
Zuckerman et al. Bone Marrow Transplant 2011;46:1226-30
![Page 60: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/60.jpg)
KPCHSCT15ptscolonizedKPC
10/15decolonized
Zuckerman et al. Bone Marrow Transplant 2011;46:1226-30
8/15BSI 4/8nodecolonized
KCPsuscepDbletoColisDna;
GentaeTige
6Death• 3deathrelatedKPCInfecDon
![Page 61: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/61.jpg)
CyclinganDbioDcinBMT• ProspecDvecohortptsneutropenicfever
Pre-cyclingPeriodAPeriodBP
• InfecDon1.000pts-day
• Gram-negaDve5.32.13.30.001• Gram-posiDve4.45.34.80.28• VRE0.11.11.60.005
Cumpstonetal.TransplInfectDis2013;15:1425
PeriodA:cycling8months
PeriodB:cycling3months
![Page 62: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/62.jpg)
PeriodA:8months PeriodB:3months
![Page 63: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/63.jpg)
AmJInfectControl2013;1167-77
![Page 64: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/64.jpg)
OtherspossibiliQesMDRdecolonizaQon
FecalTransplant• Save• CasesReports
ProbioQcs• 1trialinchildren
![Page 65: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/65.jpg)
![Page 66: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/66.jpg)
![Page 67: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/67.jpg)
![Page 68: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/68.jpg)
![Page 69: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/69.jpg)
TakeHomeMessage
TalktoyourpaDent
Screen
Local/CountryMDRRates
ClassifypaDent
UsetheinformaDonwisely
![Page 70: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/70.jpg)
![Page 71: SILVIA F. COSTA DMIP-FMUSP SILVIACOSTA@USPtheific.org/wp-content/uploads/2017/10/31.pdf · IPC in Hematology Epidemiology • Site of InfecDons • Risk Factors • Colonizaon x InfecDon](https://reader031.vdocuments.us/reader031/viewer/2022021721/5be7f5d709d3f204758db5cb/html5/thumbnails/71.jpg)
Thankyou